These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7279639)

  • 1. [Acute left ventricular failure induced by oral disopyramide. A case of a patient with Friedreich's disease].
    Nannan M; Maurier F; Grison D; Sacrez A
    Nouv Presse Med; 1981 Aug 29-Sep 5; 10(31):2587. PubMed ID: 7279639
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac problems caused by disopyramide.
    FDA Drug Bull; 1981 Mar; 11(1):4-5. PubMed ID: 7215732
    [No Abstract]   [Full Text] [Related]  

  • 3. Congestive heart failure caused by oral disopyramide.
    Podrid PJ; Schoeneberger A; Lown B
    N Engl J Med; 1980 Mar; 302(11):614-7. PubMed ID: 7351909
    [No Abstract]   [Full Text] [Related]  

  • 4. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paradoxic response to disopyramide and quinidine (author's transl)].
    Breithardt G; Seipel L; Haerten K
    Z Kardiol; 1980 Aug; 69(8):556-61. PubMed ID: 7445656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disopyramide induced atypical ventricular tachycardia.
    Chia BL
    Aust N Z J Med; 1980 Dec; 10(6):665-8. PubMed ID: 6938189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of radionuclide ventriculography for assessment of changes in myocardial performance induced by disopyramide phosphate.
    Kowey PR; Friedman PL; Podrid PJ; Zielonka J; Lown B; Wynne J; Holman BL
    Am Heart J; 1982 Oct; 104(4 Pt 1):769-74. PubMed ID: 6812403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypoglycemia induced by disopyramide. Case report].
    Chaussade S; Beucler A; Lafaix C
    Nouv Presse Med; 1982 May; 11(25):1951. PubMed ID: 7110951
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ventricular fibrillation during disopyramide treatment].
    Edhag O; Forssell G; Schenck-Gustafsson K
    Lakartidningen; 1981 Oct; 78(41):3597-600. PubMed ID: 7321703
    [No Abstract]   [Full Text] [Related]  

  • 10. Disopyramide and compromised ventricular function.
    Willis KR
    Can Med Assoc J; 1983 Feb; 128(4):372. PubMed ID: 6821793
    [No Abstract]   [Full Text] [Related]  

  • 11. [Atypical ventricular tachycardia due to disopyramide].
    Feigl D; Ashkenazi J; Schwarzmann H
    Harefuah; 1982 Mar; 102(6):246-7. PubMed ID: 7160719
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiac shock after disopyramide].
    Kannelønning KS
    Tidsskr Nor Laegeforen; 1981 Oct; 101(29):1647-8. PubMed ID: 7339947
    [No Abstract]   [Full Text] [Related]  

  • 13. Friedreich's disease--a family study.
    O'Brien ET; Dajee H; Ward OC
    Eur J Cardiol; 1977; 6(1):15-24. PubMed ID: 923620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypoglycemia complicating disopyramide (Norpace) therapy. A case report.
    Hartigan JD
    Nebr Med J; 1983 Feb; 68(2):36-8. PubMed ID: 6828201
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute cardiac failure and hepatic ischemia induced by disopyramide phosphate.
    Scheinman SJ; Poll DS; Wolfson S
    Yale J Biol Med; 1980; 53(5):361-6. PubMed ID: 7222741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiogenic shock and disopyramide phosphate.
    Story JR; Abdulla AM; Frank MJ
    JAMA; 1979 Aug; 242(7):654-5. PubMed ID: 449005
    [No Abstract]   [Full Text] [Related]  

  • 17. Disopyramide-induced ventricular arrhythmia.
    Dhurandhar RW
    Am J Cardiol; 1980 Aug; 46(2):347. PubMed ID: 7405852
    [No Abstract]   [Full Text] [Related]  

  • 18. Disopyramide-associated liver dysfunction.
    Bakris GL; Cross PD; Hammarsten JE
    Mayo Clin Proc; 1983 Apr; 58(4):265-7. PubMed ID: 6834895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Letter: Syncopes through the inversion of points in connection with the absorption of disopyramide].
    Casedevant B; Sabaut D; Clementy J; Dallocchio M
    Nouv Presse Med; 1975 Oct; 4(32):2339. PubMed ID: 1178509
    [No Abstract]   [Full Text] [Related]  

  • 20. Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.
    Riccioni N; Castiglioni M; Bartolomei C
    Am Heart J; 1983 May; 105(5):870-1. PubMed ID: 6846134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.